Yannick Le Bris

1.1k total citations
45 papers, 337 citations indexed

About

Yannick Le Bris is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Yannick Le Bris has authored 45 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 17 papers in Immunology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Yannick Le Bris's work include Acute Myeloid Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Yannick Le Bris is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Yannick Le Bris collaborates with scholars based in France, Canada and United States. Yannick Le Bris's co-authors include Marie C. Béné, Philippe Moreau, Steven Le Gouill, Céline Bellanger, Benoît Tessoulin, Patrice Chevallier, Catherine Pellat‐Deceunynck, Pierre Péterlin, David Chiron and Cyrille Touzeau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Yannick Le Bris

42 papers receiving 332 citations

Peers

Yannick Le Bris
Yannick Le Bris
Citations per year, relative to Yannick Le Bris Yannick Le Bris (= 1×) peers Massimo Fabrizio Martelli

Countries citing papers authored by Yannick Le Bris

Since Specialization
Citations

This map shows the geographic impact of Yannick Le Bris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannick Le Bris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannick Le Bris more than expected).

Fields of papers citing papers by Yannick Le Bris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannick Le Bris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannick Le Bris. The network helps show where Yannick Le Bris may publish in the future.

Co-authorship network of co-authors of Yannick Le Bris

This figure shows the co-authorship network connecting the top 25 collaborators of Yannick Le Bris. A scholar is included among the top collaborators of Yannick Le Bris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannick Le Bris. Yannick Le Bris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2026). CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival. Leukemia.
2.
Lecomte, R., J. Graveleau, Yannick Le Bris, et al.. (2024). Susceptibility to mycobacterial infection in VEXAS syndrome. Lara D. Veeken. 64(2). 831–835. 10 indexed citations
3.
Bris, Yannick Le, et al.. (2024). Obliteration of liver sinusoids through platelet aggregates associated to extramedullary haematopoiesis in myeloid neoplasms. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(3). 491–497.
4.
Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations
5.
Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations
7.
Sujobert, Pierre, Olivier Kosmider, Damien Luque Paz, et al.. (2023). Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France. HemaSphere. 7(9). e943–e943. 2 indexed citations
8.
Péterlin, Pierre, Alice Garnier, Amandine Le Bourgeois, et al.. (2023). Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial. EClinicalMedicine. 64. 102254–102254. 5 indexed citations
9.
Tamburini, Jérôme, Sarah Mouche, Clément Larrue, et al.. (2023). Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia. Blood Advances. 7(24). 7576–7580. 3 indexed citations
10.
Bris, Yannick Le, Pascal Turlure, Patrice Chevallier, et al.. (2022). Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351. Blood. 140(Supplement 1). 9821–9823. 1 indexed citations
12.
Bris, Yannick Le, Florence Magrangeas, Philippe Moreau, et al.. (2020). Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group. Hematological Oncology. 38(4). 446–455. 8 indexed citations
13.
Guillaume, Thierry, Pierre Péterlin, Alice Garnier, et al.. (2020). Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft. Scientific Reports. 10(1). 15399–15399. 2 indexed citations
14.
Tessoulin, Benoît, Céline Bellanger, Philippe Moreau, et al.. (2019). CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages. Leukemia. 33(10). 2442–2453. 53 indexed citations
16.
Garnier, Alice, Florent Delbos, Thierry Guillaume, et al.. (2018). Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. Bone Marrow Transplantation. 53(8). 1044–1047. 3 indexed citations
17.
Sujobert, Pierre, Yannick Le Bris, Laurence de Leval, et al.. (2018). Definition of a minimal genes set for mature lymphoid blood diseases. Hématologie. 24(1). 27–59. 3 indexed citations
18.
Bris, Yannick Le, Thierry Guillaume, Armelle Ménard, et al.. (2017). Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults. Bone Marrow Transplantation. 52(6). 854–858. 2 indexed citations
19.
Péterlin, Pierre, Yannick Le Bris, Catherine Godon, et al.. (2016). Interest of the XN-10® Analyzer to Screen for Myelodysplastic Syndromes on Complete Blood Count (CBC) Especially with Hemoglobin Levels and Neut-WX. Blood. 128(22). 5518–5518. 3 indexed citations
20.
Salameire, Dimitri, Yannick Le Bris, Blandine Fabre, et al.. (2009). Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry. Cytometry Part A. 75A(9). 743–751. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026